UBE2S and UBE2C confer a poor prognosis to breast cancer via downregulation of Numb

Overview of attention for article published in Frontiers in oncology, February 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 8 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 24,180 followers.

UBE2S and UBE2C confer a poor prognosis to breast cancer via downregulation of Numb https://t.co/r4RDRdiqpD

02 Mar 2023

Reply Repost Favourite

UBE2S and UBE2C confer a poor prognosis to breast cancer via downregulation of Numb https://t.co/9PLYJRbTzt https://t.co/zoYB6L8Jfs

16 Feb 2023

Reply Repost Favourite

New research: UBE2S and UBE2C confer a poor prognosis to breast cancer via downregulation of Numb: Purpose Ubiquitin-conjugating enzymes E2S (UBE2S) and E2C (UBE2C), which mediate the biological process of ubiquitination, have been widely… https://t.co/Jc

14 Feb 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.